| http://www.w3.org/ns/prov#value | - In preclinical studies DEP??? docetaxel has shown significant tumour-targeting and superior anti-cancer effects across a range of important cancer types including breast, prostate, lung and ovarian tumour, when compared to Taxotere?? (docetaxel).
|
